1,980
Participants
Start Date
September 30, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
DADA LINK
"Intervention facilities will receive the DADA-LINK intervention, comprised of:~1. HPV self-sampling: We will provide clinics with HPV self-sampling kits to administer to eligible patients.~2. Care Navigation: One study-supported non-physician care navigator will be assigned to each clinic to support the clinic staff. These trained individuals will be responsible for managing data collection through the mHealth platform to aid the coordination of services and for motivating the clinic staff to adhere to cervical cancer care guidelines.~3. mHealth support for cervical cancer screening and treatment linkage: The WEMA application is a low-cost and highly adaptable open-source application designed for cervical cancer data monitoring and evaluation. Relevant patient information and data on uptake of cervical cancer screening and triage/treatment will be entered in the WEMA platform. The platform will additionally be used to send text messages to patients to facilitate clinic attendance."
Kenyatta National Hospital, Nairobi
Emory University
OTHER
University of Washington
OTHER
National Cancer Institute (NCI)
NIH
Kenya Ministry of Health
OTHER_GOV
Queen's University
OTHER
University of Nairobi
OTHER
Kenyatta National Hospital
OTHER_GOV